A Pilot Study of Consolidative Immunotherapy in Patients with High-Risk Pediatric Sarcomas

PURPOSE: Patients with metastatic or recurrent Ewing’s sarcoma (ESFT) and alveolar rhabdomyosarcoma (AR) have <25% 5-yr. survival in most studies. This study administered a novel immunotherapy regimen aimed at consolidating remission in these patients. EXPERIMENTAL DESIGN: 52 patients with transl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mackall, Crystal L., Rhee, Eunice H., Read, Elizabeth J., Khuu, Hanh M., Leitman, Susan F., Bernstein, Donna, Tesso, Merertu, Long, Lauren M., Grindler, David, Merino, Margret, Kopp, William, Tsokos, Maria, Berzofsky, Jay A., Helman, Lee J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2497450/
https://ncbi.nlm.nih.gov/pubmed/18676758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-07-4065
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados